Japan Overview

Increasingly, Japanese pharmaceutical companies are expanding their activities into the U.S., Europe and other markets. At the same time, more and more multinationals are discovering the potential of the Japanese market.

With nine facilities in Japan, Quintiles Japan has developed the special expertise to help you achieve your goals:

• In-country drug development
• Accelerated Japanese approvals through offshore trials
• Services for Japanese companies selling into Europe, the U.S. and other markets
• Flexible, high-quality, cost-effective capabilities
• Effective pharmaceutical sales and marketing plans